Trial Details
TERMINATEDBasic Information
| Clinical ID | c2490 |
|---|---|
| Identifier | NCT03415711 |
| Trial Title | PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DIETARY_SUPPLEMENT: VSL#3®|DRUG: Mesalamine|DRUG: Placebo |
Participant Information
| Sponsor | VSL Pharmaceuticals |
|---|---|
| City | Roma |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2017-04-28 |
|---|---|
| Primary Completion Date | 2019-04-24 |
| Completion Date | 2019-04-24 |